- Home
- PLX vs VPV Comparison
PLX vs VPV Comparison
Compare PLX & VPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- VPV
- Stock Information
- Founded
- PLX 1993
- VPV 1993
- Country
- PLX Israel
- VPV United States
- Employees
- PLX N/A
- VPV N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- VPV Trusts Except Educational Religious and Charitable
- Sector
- PLX Health Care
- VPV Finance
- Exchange
- PLX Nasdaq
- VPV Nasdaq
- Market Cap
- PLX 160.2M
- VPV 185.3M
- IPO Year
- PLX 1998
- VPV N/A
- Fundamental
- Price
- PLX $2.59
- VPV $10.27
- Analyst Decision
- PLX Strong Buy
- VPV
- Analyst Count
- PLX 1
- VPV 0
- Target Price
- PLX $15.00
- VPV N/A
- AVG Volume (30 Days)
- PLX 764.3K
- VPV 36.6K
- Earning Date
- PLX 03-17-2025
- VPV 01-01-0001
- Dividend Yield
- PLX N/A
- VPV 3.60%
- EPS Growth
- PLX N/A
- VPV N/A
- EPS
- PLX 0.04
- VPV N/A
- Revenue
- PLX $53,399,000.00
- VPV N/A
- Revenue This Year
- PLX $67.17
- VPV N/A
- Revenue Next Year
- PLX $55.31
- VPV N/A
- P/E Ratio
- PLX $71.07
- VPV N/A
- Revenue Growth
- PLX N/A
- VPV N/A
- 52 Week Low
- PLX $0.82
- VPV $8.58
- 52 Week High
- PLX $2.76
- VPV $10.28
- Technical
- Relative Strength Index (RSI)
- PLX 58.97
- VPV 43.89
- Support Level
- PLX $2.43
- VPV $10.12
- Resistance Level
- PLX $2.62
- VPV $10.44
- Average True Range (ATR)
- PLX 0.14
- VPV 0.10
- MACD
- PLX 0.02
- VPV -0.01
- Stochastic Oscillator
- PLX 85.00
- VPV 42.86
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About VPV Invesco Pennsylvania Value Municipal Income Trust (DE)
Invesco Pennsylvania Value Municipal Income Trust is a diversified, closed-end management investment company. The investment objective is to provide common shareholders with a high level of current income exempt from federal and Pennsylvania income taxes and, where possible under local law, local income and personal property taxes, consistent with preservation of capital.